Disease-modifier Drugs in Patients with Advanced Heart Failure
Author:
Funder
AstraZeneca
Boehringer Ingelheim
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference103 articles.
1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials;Garg;JAMA,1995
3. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group;Hjalmarson;JAMA,2000
4. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group;Packer;N Engl J Med,1996
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study;Journal of Clinical Medicine;2022-07-21
2. Advanced heart failure: state of the art and future directions;Reviews in Cardiovascular Medicine;2022-02-08
3. Retos en el abordaje de pacientes con insuficiencia cardiaca y fracción de eyección reducida;Revista Española de Cardiología Suplementos;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3